Since 2013, we have focused on HAdV-associated urethritis and performed pathogen screening from the urine of all-male patients with acute urethritis at iClinic in Sendai City, Miyagi Prefecture, Japan; all patients gave informed consent (reference 16 in Appendix). Recently, several papers have reported that HAdVs are ranked the third- or fourth-highest causative agents of nonchlamydial, nongonococcal urethritis (reference 17 in Appendix). Furthermore, HAdVs most commonly associated with urethritis are those that cause epidemic keratoconjunctivitis, which are types D37, D56, and D64 (references 16,18 in Appendix).

Figure 1

Figure 1. Clinical course and laboratory test results for patient with HAdV B7d–associated urethritis, Japan. HAdV, human adenovirus

In July 2018, a case of male urethral inflammation associated with HAdV-B7d was detected in a 22-year-old heterosexual man. He was unmarried and did not have a specific sexual partner. He had an unremarkable medical history, no history of sexually transmitted infections, and no record of traveling abroad. He claimed to have had 2 sexual encounters during his lifetime; the first was in 2016, but the second, in 2018, we considered to be the putative infection day (day 0) (Figure 1). He described it as a casual sexual encounter with a previously unknown woman and reported the encounter to include protected vaginal intercourse, cunnilingus, and unprotected oral intercourse. The patient denied insertive or receptive anal intercourse as well as mouth-to-mouth kissing. Urethral irritation and dysuria appeared on day 1 and continued to develop gradually (Figure 1); these symptoms might be caused by mechanical irritation. On day 15, the patient experienced the most pain from his symptoms, reporting a numerical rating scale score of 5/10 and a visual analog scale score of 4.8/10. These scales are subjective scores of pain (reference 19 in Appendix). Pharyngitis and conjunctivitis appeared on day 17. On day 19, he visited an ophthalmic clinic for confirmation of conjunctivitis; however, it was not considered to be adenoviral conjunctivitis because an adenoviral immunochromatographic kit produced a negative result. Fluorometholone and levofloxacin eye drops were prescribed. Because his urethritis symptoms were severe, he visited a sexually transmitted diseases clinic (Sendai city, Miyagi prefecture, Japan) on day 20. The patient reported no fever, chills, or malaise; on the basis of his symptoms and results of a physical examination (Figure 1), we diagnosed nongonococcal urethritis. Because we could not exclude the possibility of bacterial infection, we prescribed sitafloxacin hydrate (200 mg/d for 7 days). Pathogen screening at the first visit to the clinic detected Haemophilus parainfluenzae bacteria from urethral discharge, but the clinical significance was unclear.

Figure 2

Figure 2. Phylogenetic analysis of human adenovirus genome type 7 whole-genome sequencing in study of human adenovirus B7d–associated urethritis, Japan. We isolated 293 strain and compared it with other human adenovirus type 7...

We isolated HAdV in A549 cells from first-void urine, throat gargle, and eye discharge fluid by a previously described method (reference 16 in Appendix). No other pathogens were identified. Sequences of the HAdV hexon, fiber, and penton open reading frames obtained by Sanger sequencing from all 3 specimen sources were identical. The full genome sequence was obtained from the urine isolate (designated strain 293) (Appendix Tables 1, 2) and deposited in GenBank (accession no. LC530212). We also performed a BLAST analysis (https://blast.ncbi.nlm.nih.gov/Blast.cgi) as previously described (2) with reference sequences of HAdV type 7 (Appendix Figure 1; Figure 2). On the basis of the phylogenetic tree analysis of whole-genome sequences, we classified the isolated HAdV-B7 strain into the same cluster as HAdV-B7d. In addition, we performed an in silico analysis of the genome using Restriction Analyzer software (http://www.molbiotools.com/restrictionanalyzer.html) by comparing the patterns of the 293 isolate with a reference HAdV-7d sequence and the following enzymes: BamHI, BclI, BstEII, HpaI, and SmaI (Appendix Figure 2). After these analyses, we identified the 293 isolate as HAdV-7d. On the basis of these results, we concluded that the patient acquired the HAdV-B7d infection, which caused urethritis, conjunctivitis, and pharyngitis, during sexual intercourse. All symptoms disappeared by day 23. When the patient revisited the clinic on day 30, he had no urethral symptoms. We detected HAdV-B7d strains isolated from first-void urine and gargle but not from eye discharge; no other pathogens tested in this study were detected. On day 40, the patient’s third visit to the clinic, no pathogens were detected. Approximately 2 months later, no symptoms were observed, and we confirmed a good prognosis.

HAdVs infect mucous membranes and can infect the urethra. Documented cases of HAdV urethritis are most often associated with certain species D HAdVs that cause epidemic keratoconjuctivitis (references 16–18 in Appendix). Our finding of HAdV-B7d, a virus more commonly associated with acute respiratory infections, in this patient was unexpected. Although we identified H. parainfluenza from urethral discharge at the first clinic visit, we suspect that it may have contributed to but not caused the patient’s primary symptoms. The isolated HAdV-B7d strains in this study were excreted in urine and gargle for >1 week after all symptoms had disappeared (Figure 1), which suggests that HAdV-B7d infection may cause urethritis and involve viral shedding into urine.